Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location

Researchers characterized the heterogeneity in the speed, magnitude, and timing of 13 SARS-CoV-2 variant transitions/waves.

23 Nov 2022

Study shows clear shifts in SARS-CoV-2 mutational spectrum during evolution

Researchers examined whether the mutational process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) itself has changed during the evolution of SARS-CoV-2.

23 Nov 2022

A work-from-home culture takes root in California

Even as pandemic lockdowns fade into memory, covid-19 has transformed California's workplace culture in ways researchers say will reverberate well beyond 2022.

23 Nov 2022

New MRI machine reveals tiny changes in the brain related to transient global amnesia

Over three hundred Norwegians experience temporary memory loss each year, but the cause has until now been difficult to discern with brain scans.

22 Nov 2022

Study investigates spread of Klebsiella superbug between humans and the environment

An international team of scientists investigating transmission of a deadly drug-resistant bacteria that rivals MRSA, has found that whilst the bugs are found in livestock, pets and the wider environment, they are rarely transmitted to humans through this route.

22 Nov 2022

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Infectious diseases expert George Thompson has been studying and treating fungal diseases for over two decades. He monitors their spread, symptoms and relative risks.

22 Nov 2022

Remdesivir appears to make a big difference in Japanese patients with COVID-19

The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial.

22 Nov 2022

New EULAR recommendations for screening and treating infections in AIIRD patients

It is already known that people who are immunocompromised are more prone to infections. Chronic and opportunistic infections are often found in people with an AIIRD, and may be linked to some of the immunosuppressive and immunomodulatory treatments used to treat these rheumatic diseases.

22 Nov 2022

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Researchers conducted a retrospective analysis to investigate the impact of vaccine-sharing strategies on the heterogenous global distribution of COVID-19 vaccines.

22 Nov 2022

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

Researchers explored active and passive vaccination among children against respiratory syncytial virus (RSV).

22 Nov 2022

Treating long covid is rife with guesswork

Medical equipment is still strewn around the house of Rick Lucas, 62, nearly two years after he came home from the hospital. He picks up a spirometer, a device that measures lung capacity, and takes a deep breath — though not as deep as he'd like.

22 Nov 2022

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Researchers assessed the effectiveness of SARS-CoV and SARS-CoV-2 envelope proteins against HIV-1.

22 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

The WHO announces four MERS cases from Saudi Arabia in recent weeks

A recent disease outbreak alert released by the World Health Organization (WHO) reported four laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) from three regions in the Kingdom of Saudi Arabia.

21 Nov 2022

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America's healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

21 Nov 2022

Johns Hopkins experts receive PCORI funding to optimize antibiotic therapy for gram-negative bloodstream infections

To study how best to treat potentially dangerous infections commonly seen in people with underlying chronic medical conditions, two infectious disease experts at Johns Hopkins Medicine have been awarded $10 million in research funding over five years by the Patient-Centered Outcomes Research Institute.

21 Nov 2022

The Native Antigen Company introduces new range of influenza antigens

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.

From The Native Antigen Company 21 Nov 2022

WHO‒recommended alcohol-based hand rub formulations show efficacy against Monkeypox virus

Previous
1
...
93
94
95
96
97
98
99
...
1167
Next

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location

Study shows clear shifts in SARS-CoV-2 mutational spectrum during evolution

A work-from-home culture takes root in California

New MRI machine reveals tiny changes in the brain related to transient global amnesia

Study investigates spread of Klebsiella superbug between humans and the environment

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Remdesivir appears to make a big difference in Japanese patients with COVID-19

New EULAR recommendations for screening and treating infections in AIIRD patients

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

Treating long covid is rife with guesswork

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Exploring antibiotic resistance in the EU

The WHO announces four MERS cases from Saudi Arabia in recent weeks

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Johns Hopkins experts receive PCORI funding to optimize antibiotic therapy for gram-negative bloodstream infections

The Native Antigen Company introduces new range of influenza antigens

WHO‒recommended alcohol-based hand rub formulations show efficacy against Monkeypox virus

Some parents may delay or avoid talking about vaccines with their child’s primary care provider

Tackling Antimicrobial Resistance; A Conversation with the World Health Organisation

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in